Article
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jun 2009
Glynn Sharon A, Boersma Brenda J, Howe Tiffany M, Edvardsen Hege, Geisler Stephanie B, Goodman Julie E, Ridnour Lisa A, Lønning Per E, Børresen-Dale Anne-Lise, Naume Bjorn, Kristensen Vessela N, Chanock Stephen J, Wink David A, Ambs Stefan
Abstract excerpt
PURPOSE: Manganese superoxide dismutase protects against oxidative damage and modulates the efficacy of chemotherapeutic drugs. A functional single-nucleotide polymorphism in codon 16 of SOD2 (rs4880), which encodes manganese superoxide dismutase, results in a substitution of valine by alanine (V...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
